Oxaprozin
From Wikipedia, the free encyclopedia
Oxaprozin
|
|
Systematic (IUPAC) name | |
3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid | |
Identifiers | |
CAS number | 21256-18-8 |
ATC code | M01AE12 |
PubChem | 4614 |
DrugBank | APRD00030 |
Chemical data | |
Formula | C18H15NO3 |
Mol. weight | 293.317 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 99% |
Metabolism | ? |
Half life | 54.9 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Oxaprozin (brand name: Daypro®) is a nonnarcotic, nonsteroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. Chemically, it is a propionic acid derivative. Available in 600mg tablets. Normal adult dosage is 1200mg daily, not to exceed 1800mg per day.